Edwards Lifesciences (EW) Asset Writedowns and Impairment (2017 - 2026)
Edwards Lifesciences' quarterly Asset Writedowns and Impairment came in at $123.6 million in Q1 2026, down 15.86% quarter-over-quarter from $146.9 million in Q4 2025.
Edwards Lifesciences has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $123.6 million in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $123.6 million; the trailing twelve-month figure through Mar 2026 stood at $357.6 million (changed N/A YoY), and the FY2025 full-year result was $186.9 million, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $123.6 million, down from $146.9 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $146.9 million in Q4 2025, with the low at $40.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.60 Mn |
| Mar 31, 2026 | 123.60 Mn |
| Dec 31, 2025 | 146.90 Mn |
| Dec 31, 2025 | 146.90 Mn |
| Sep 30, 2025 | 40.00 Mn |
| Sep 30, 2025 | 40.00 Mn |
| Jun 30, 2025 | 47.10 Mn |
| Jun 30, 2025 | 47.10 Mn |
| Sep 30, 2019 | 26.90 Mn |
| Sep 30, 2019 | 26.90 Mn |
| Jun 30, 2019 | 46.20 Mn |
| Jun 30, 2019 | 46.20 Mn |
| Dec 31, 2017 | -31.00 Mn |
| Dec 31, 2017 | -31.00 Mn |